These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19609506)

  • 1. Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect.
    Fendt M; Bürki H; Imobersteg S; Lingenhöhl K; McAllister KH; Orain D; Uzunov DP; Chaperon F
    Psychopharmacology (Berl); 2009 Oct; 206(2):291-301. PubMed ID: 19609506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors.
    Sparrow AM; Lowery-Gionta EG; Pleil KE; Li C; Sprow GM; Cox BR; Rinker JA; Jijon AM; Peňa J; Navarro M; Kash TL; Thiele TE
    Neuropsychopharmacology; 2012 May; 37(6):1409-21. PubMed ID: 22218088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle.
    Gutman AR; Yang Y; Ressler KJ; Davis M
    J Neurosci; 2008 Nov; 28(48):12682-90. PubMed ID: 19036961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
    Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
    Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice.
    Karlsson RM; Choe JS; Cameron HA; Thorsell A; Crawley JN; Holmes A; Heilig M
    Psychopharmacology (Berl); 2008 Jan; 195(4):547-57. PubMed ID: 17891380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
    Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term enriched environment exposure facilitates fear extinction in adult rats: The NPY-Y1 receptor modulation.
    Lach G; Bicca MA; Hoeller AA; Santos EC; Costa AP; de Lima TC
    Neuropeptides; 2016 Feb; 55():73-8. PubMed ID: 26490304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y Reduces Social Fear in Male Mice: Involvement of Y1 and Y2 Receptors in the Dorsolateral Septum and Central Amygdala.
    Kornhuber J; Zoicas I
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPY Y2 receptors in the central amygdala reduce cued but not contextual fear.
    Verma D; Wood J; Lach G; Mietzsch M; Weger S; Heilbronn R; Herzog H; Bonaventure P; Sperk G; Tasan RO
    Neuropharmacology; 2015 Dec; 99():665-74. PubMed ID: 26314208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y directly inhibits neuronal activity in a subpopulation of gonadotropin-releasing hormone-1 neurons via Y1 receptors.
    Klenke U; Constantin S; Wray S
    Endocrinology; 2010 Jun; 151(6):2736-46. PubMed ID: 20351316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.
    Parrado C; Díaz-Cabiale Z; García-Coronel M; Agnati LF; Coveñas R; Fuxe K; Narváez JA
    Neuropharmacology; 2007 Feb; 52(2):684-92. PubMed ID: 17087983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal fluctuations in HPA and neuropeptide Y-ergic systems underlie differences in vulnerability to traumatic stress responses at different zeitgeber times.
    Cohen S; Vainer E; Matar MA; Kozlovsky N; Kaplan Z; Zohar J; Mathé AA; Cohen H
    Neuropsychopharmacology; 2015 Feb; 40(3):774-90. PubMed ID: 25241802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.
    Heilig M
    Regul Pept; 1995 Oct; 59(2):201-5. PubMed ID: 8584755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of neuropeptide Y and Y1 receptor expression in the amygdala by fluctuations in the brain content of neuroactive steroids during ethanol drinking discontinuation in Y1R/LacZ transgenic mice.
    Eva C; Mele P; Collura D; Nai A; Pisu MG; Serra M; Biggio G
    J Neurochem; 2008 Feb; 104(4):1043-54. PubMed ID: 18036156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors.
    Kornhuber J; Zoicas I
    J Psychopharmacol; 2019 Dec; 33(12):1533-1539. PubMed ID: 31328614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hepatic neuropeptide Y-Y1 receptors in a methionine-choline-deficient model of non-alcoholic steatohepatitis.
    Sun WW; ShangGuan T; Zhu P; Li HK; Jiang M; Yang P; Li LY; Zhang ZH
    Life Sci; 2020 Mar; 245():117356. PubMed ID: 31991181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NPY Y1 receptor on acquisition, consolidation and extinction on contextual fear conditioning: dissociation between anxiety, locomotion and non-emotional memory behavior.
    Lach G; de Lima TC
    Neurobiol Learn Mem; 2013 Jul; 103():26-33. PubMed ID: 23603424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats.
    Sajdyk TJ; Schober DA; Gehlert DR
    Neuropharmacology; 2002 Dec; 43(7):1165-72. PubMed ID: 12504923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-amygdala injections of neuropeptide S block fear-potentiated startle.
    Fendt M; Imobersteg S; Bürki H; McAllister KH; Sailer AW
    Neurosci Lett; 2010 May; 474(3):154-157. PubMed ID: 20298749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of ligand binding modes at the neuropeptide Y Y
    Yang Z; Han S; Keller M; Kaiser A; Bender BJ; Bosse M; Burkert K; Kögler LM; Wifling D; Bernhardt G; Plank N; Littmann T; Schmidt P; Yi C; Li B; Ye S; Zhang R; Xu B; Larhammar D; Stevens RC; Huster D; Meiler J; Zhao Q; Beck-Sickinger AG; Buschauer A; Wu B
    Nature; 2018 Apr; 556(7702):520-524. PubMed ID: 29670288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.